List view / Grid view
11 October 2016 | By Niamh Louise Marriott, Digital Content Producer
DS-8201a is an investigational antibody drug conjugate comprised of a humanised anti-HER2 antibody attached by a peptide linker to a novel topoisomerase...
11 October 2016 | By Niamh Louise Marriott, Digital Content Producer
This recommendation means that patients in Scotland will become the first in the UK to be treated with nivolumab on the NHS...
10 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The results demonstrate that LEE011 plus letrozole reduced the risk of death or progression by 44%. The combination significantly improved PFS across...
10 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The new data-driven tech, OncoPortal, improves the diagnosis and treatment of solid tumours and haematological malignancies for patients around the world...
10 October 2016 | By Niamh Louise Marriott, Digital Content Producer
An immunotherapy drug has been hailed as a ‘game changer’ after being found to greatly improve survival for patients with relapsed head and neck cancer...
7 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The VTS-270 clinical program is aimed at treating the neurological disease that is the primary cause of child mortality with Niemann-Pick Type C1 disease...
7 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Once final guidance is published, dapagliflozin will join two other similar drugs, empagliflozin and canagliflozin, as options for triple therapy...
6 October 2016 | By CI Precision
Venezuela’s largest pharmaceutical manufacturer, Laboratorios Leti S.A.V. is using the Ci-DMS Weigh and Dispense module from CI Precision to dispense both raw and packing materials for their processing plant...
6 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Following review of the safety data, the DSMB authorised that the clinical trial proceed with enrolment and dose escalation for the second cohort...
6 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The Patent Trial and Appeal Board (PTAB) found that the patent was valid in light of the challenges put forward by the petitioner...
5 October 2016 | By Pall Life Sciences
Pall Life Sciences is pleased to announce the commercial launch of the Cadence BioSMB Process system single-use flow path, continuous multi-column chromatography system...
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
RedHill Biopharma, will shortly commence a study evaluating yeliva (ABC294640) in patients with advanced hepatocellular carcinoma (HCC), pending final...
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Data demonstrated that Novacyt’s proprietary technology platform, NOVAprep, and Cepheid’s Xpert HPV test produced highly accurate results...
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Nanobiotix, a late clinical-stage nanomedicine company, has appointed Dr Mihail Obrocea as the Head of US Clinical Development and Noel Kurdi as the Director of Investor Relations. In the US, Nanobiotix has filed a new drug application for NBTXR3, as a treatment for prostate cancer and plans to initiate a…
5 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The company expects to complete the submission of the new drug application (NDA) for vyxeos by early 2017, and will request a priority review...
